Cleared Special

K232389 - Carescape SpO2 - Masimo

Also marketed or referenced as:
Masimo rainbow SET IntelliVue

K232389 is the FDA 510(k) clearance for Carescape SpO2 - Masimo by Masimo Corporation. It is a Class 2 Anesthesiology device (product code DQA) cleared through the Special 510(k) pathway after a 29-day FDA review.

K232389 · Masimo Corporation · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2023
Decision
29d
Days
Class 2
Risk

K232389 is an FDA 510(k) clearance for the Carescape SpO2 - Masimo. Classified as Oximeter (product code DQA), Class II - Special Controls.

Submitted by Masimo Corporation (Irvine, US). The FDA issued a Cleared decision on September 7, 2023 after a review of 29 days - a notably fast clearance cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 870.2700 - the FDA anesthesiology and respiratory device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Masimo Corporation devices

Submission Details

510(k) Number K232389 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 09, 2023
Decision Date September 07, 2023
Days to Decision 29 days
Submission Type Special
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
111d faster than avg
Panel avg: 140d · This submission: 29d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code DQA Oximeter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2700
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - DQA Oximeter

All 367
Devices cleared under the same product code (DQA) and FDA review panel - the closest regulatory comparables to K232389.
Masimo Stork
K223721 · Masimo Corporation · Dec 2023
Wrist Pulse Oximeter
K230587 · Beijing Choice Electronic Technology Co., Ltd. · Nov 2023
Finger Clip Pulse Oximeter
K231243 · Guangdong Genial Technology Co., Ltd. · Oct 2023
circul™ pro Ring
K221361 · Bodimetrics, LLC · Aug 2023
Pulse Oximeter
K230172 · Beijing Choice Electronic Technology Co., Ltd. · Aug 2023
Pulse Oximeter
K211143 · Shenzhen Brav Electronic Technologies Co., Ltd. · Jul 2023